Coronavirus disease 2019 (COVID-19) impact on central-line-associated bloodstream infections (CLABSI): a systematic review by Giovanni Satta, Timothy M. Rawson, Luke S.P. Moore

Get full text

Bacterial peritonitis in paediatric appendicitis; microbial epidemiology and antimicrobial management by Keir Bhaskar, Simon Clarke, Luke S. P. Moore, Stephen Hughes

Get full text

A case of ceftriaxone-induced immune haemolytic anaemia in an ambulatory care setting by Rakhee Mistry, Luke S.P. Moore, Nabeela Mughal, Andrew Godfrey, Stephen Hughes

Get full text

Haematological and hepatic adverse effects of ceftriaxone in ambulatory care: a dual-centre retrospective observational analysis of standard vs high dose by Rakhee Mistry, Timothy M. Rawson, Oliver Troise, Nabeela Mughal, Luke S. P. Moore, Stephen Hughes

Get full text

Navigating the Current Treatment Landscape of Metallo-β-Lactamase-Producing Gram-Negative Infections: What are the Limitations? by Beatrice Grabein, Francis F. Arhin, George L. Daikos, Luke S. P. Moore, V. Balaji, Nathalie Baillon-Plot

Get full text

Resistance Trend Estimation Using Regression Analysis to Enhance Antimicrobial Surveillance: A Multi-Centre Study in London 2009–2016 by Bernard Hernandez, Pau Herrero-Viñas, Timothy M. Rawson, Luke S. P. Moore, Alison H. Holmes, Pantelis Georgiou

Get full text

Waterborne Elizabethkingia meningoseptica in Adult Critical Care by Luke S.P. Moore, Daniel S. Owens, Annette Jepson, Jane F. Turton, Simon Ashworth, Hugo Donaldson, Alison H. Holmes

Get full text

Rapid Diagnostic Test Value and Implementation in Antimicrobial Stewardship Across Low-to-Middle and High-Income Countries: A Mixed-Methods Review by Luke S. P. Moore, Maria Virginia Villegas, Eric Wenzler, Timothy M. Rawson, Rita O. Oladele, Yohei Doi, Anucha Apisarnthanarak

Get full text

An Insurance Value Modeling Approach That Captures the Wider Value of a Novel Antimicrobial to Health Systems, Patients, and the Population by Mei S. Chan, Richard Holloway, Robert King, Rosie Polya, Rebecca Sloan, Jack C. Kowalik, Tom Ashfield, Luke S.P. Moore, Thomas Porter, Jonathan Pearson-Stuttard

Get full text

Global trends in carbapenem- and difficult-to-treat-resistance among World Health Organization priority bacterial pathogens: ATLAS surveillance program 2018–2022 by Mark G. Wise, James A. Karlowsky, Naglaa Mohamed, Elizabeth D. Hermsen, Shweta Kamat, Andy Townsend, Adrian Brink, Alex Soriano, David L. Paterson, Luke S.P. Moore, Daniel F. Sahm

Get full text

Hybrid immunity in older adults is associated with reduced SARS-CoV-2 infections following BNT162b2 COVID-19 immunisation by Scott J. C. Pallett, Joseph Heskin, Fergus Keating, Andrea Mazzella, Hannah Taylor, Aatish Patel, Georgia Lamb, Deborah Sturdy, Natalie Eisler, Sarah Denny, Esmita Charani, Paul Randell, Nabeela Mughal, Eleanor Parker, Carolina Rosadas de Oliveira, Michael Rayment, Rachael Jones, Richard Tedder, Myra McClure, Elisabetta Groppelli, Gary W. Davies, Matthew K. O’Shea, Luke S. P. Moore

Get full text

An analysis of existing national action plans for antimicrobial resistance—gaps and opportunities in strategies optimising antibiotic use in human populations by Esmita Charani, PhD, Marc Mendelson, ProfPhD, Scott J C Pallett, MRCP, Raheelah Ahmad, PhD, Mirfin Mpundu, PhD, Oluchi Mbamalu, PhD, Candice Bonaconsa, MSc, Vrinda Nampoothiri, DPharm, Sanjeev Singh, PhD, Nathan Peiffer-Smadja, PhD, Vanesa Anton-Vazquez, MD, Luke S P Moore, PhD, Jeroen Schouten, PhD, Tomislav Kostyanev, PhD, Vera Vlahović-Palčevski, MD, Diamantis Kofteridis, PhD, Juliana Silva Corrêa, PhD, Alison H Holmes, ProfMD

Get full text